Profil
Julia Tsai is Senior VP-Clinical Development & Medical Affairs at Ovid Therapeutics, Inc. since 2021.
Formerly, Dr. Tsai was Vice President-Clinical Director at Immedica Pharma US, Inc. from 2004 to 2020.
Education includes undergraduate studies at Cornell University and a doctorate from New York University School of Medicine.
Postes actifs de Julia Tsai
| Sociétés | Poste | Début |
|---|---|---|
| OVID THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 08/07/2021 |
Anciens postes connus de Julia Tsai
| Sociétés | Poste | Fin |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2020 |
Formation de Julia Tsai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















